908 Devices (MASS) to Release Quarterly Earnings on Tuesday

908 Devices (NASDAQ:MASS) is anticipated to release its Q1 2025 earnings data before the market opens on Tuesday, May 13th. Analysts expect 908 Devices to post earnings of ($0.29) per share and revenue of $11.90 million for the quarter.

908 Devices Trading Down 3.6 %

MASS stock opened at $5.40 on Tuesday. The company has a market capitalization of $193.00 million, a P/E ratio of -3.05 and a beta of 0.26. The business has a 50 day simple moving average of $4.20 and a 200-day simple moving average of $3.16. 908 Devices has a twelve month low of $1.81 and a twelve month high of $7.48.

Analysts Set New Price Targets

MASS has been the subject of several recent analyst reports. Stephens restated an “overweight” rating and issued a $6.00 target price on shares of 908 Devices in a research note on Wednesday, January 15th. Weiss Ratings reiterated a “sell (d-)” rating on shares of 908 Devices in a research report on Thursday, April 24th. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $5.33.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.